PHARVAT is a European Commission (EC) Seventh Framework Programme (FP7) funded project aiming to generate a harmonised procedure to permit pre-clinical selection of vaccine adjuvants. The project is running for a two year period and was initiated in November 2009 with an overall budget of € 300 000.


11 December 2014

Malaria Vaccine Development in Europe Workshop

Ninety people registered for the workshop, which was held at Louise Centre, Avenue Louise 287, Brussels

EVI valued your participation and extends heartfelt thanks for your contribution.  We are sure you join EVI in looking forward to witnessing the benefits of the workshop throughout the scientific community.

A report will be available at a later date, alternatively an article is being considered

03 November 2014

SEmalvac consortium call for the monitoring of a phase I clinical trial

This call is for a suitable independent Clinical Research Assistant (CRA) or a Contract Research Organisation (CRO) for the monitoring of a phase I clinical in CNRFP, Burkina Faso.

24 October 2014

EVI support leads to scientific breakthrough

A letter was published in Nature on 17 August fully acknowledging EVI and the InnoMalVac project.  Access to the structure is now paving the way forward to design improved vaccines against RH5, as well as the other RH malaria proteins.